SBWire

CorAssist Cardiovascular Ltd. (CorAssist) is a medical device company, based in Israel. It develops and manufactures innovative therapeutic products for the cardiovascular market. The company develops products such as invasive medical devices and intraventricular devices that are used in the treatment of diastolic heart failure. Its product portfolio includes ImCardia, ImCardia MIS and Aurora. CorAssist develops elastic and self-expanding devices, which operate by transferring energy harnessed during systole to the left ventricle during diastole for improved diastolic performance. It utilizes its patented technology for the implantation of the devices that improves cardiac diastolic function. CorAssist is headquartered in Hezliya Pitauch, Israel.

Toscana Biomarkers Srl (Toscana) is a biotechnological research and development company, based in Italy. The company develops and validates innovative technologies in the field of molecular diagnostics. It operates through product segments such as biomarkers and diagnostic tests. Biomarkers are decision-making tools at the basis of clinical diagnostics and essential for guiding therapeutic treatments. In vitro tests based on the detection of antibodies as disease biomarkers can be efficiently used for the diagnosis and the follow-up of autoimmune disorders. In vitro tests such as autoantibody blood tests, blood tests to measure inflammation and organ function, clinical presentation, and MRI examinations. Toscana is headquartered in Siena, Italy.

Innovia LLC (Innovia) is a medical device company, based in the US. It designs and develops medical devices and biomaterials. The company’s products include biomaterials and devices. Its biomaterial products include innoseal, quatromer, quatroset, and SIBS. The company’s pipeline product includes bariatrics, cardiovascular, cosmetic surgery, materials, ophthalmology, orthopedics, and oculoplasty. It operates through a network of laboratories, physicians, and hospitals to research, develop, and manufacture innovative device solutions. The company provides services such as, contract manufacturing, designing and developing devices and polymers, and conducting research and development programs for clients. It is certified with ISO 13485. Innovia is headquartered in Miami, Florida, the US.

Nutek Orthopaedics, LLC (Nutek Orthopaedics) is a medical device company based in the US. The company designs, develops and markets medical devices for the orthopedic markets. Its first products are NBX-non-bridging external fixator and the first assistant- wrist fracture reduction device. The devices of the company are fabricated in lightweight, durable biopolymers. The orthopaedic devices of Nutek Orthopaedics include periarticular fixation devices and bone augmentations earmarked to preserve joint motion after the repair of devastating musculoskeletal injuries. The products of the company will encourage patients to exercise without fear of re-injury. Nutek Orthopaedics is headquartered in Fort Lauderdale, Florida, the US.

Digna Biotech, S.L. (Digna) is a pharmaceutical and healthcare company, based in Spain. The company develops and commercializes pharmaceutical products discovered by the Centre for Applied Medical Research in Pamplona. It aims to implement preclinical studies and run clinical trials to document the existing products. The company offers products in two areas that are therapeutic area and diagnostic area. Its therapeutic products include P144, P17, IFN alfa 5, cardiotrophine, AAV-phorphyria, Ad/SFA, amphiregulin in acute hepatic diseases and IFN+CTI+oncostatin. The company’s diagnostic products include urifib, apo a1, HCC molecular markers, osteoscarcoma prognostic markers, MTA prog. treatment markers, M.E. metabolomics prog. markers and melanocytes test. Digna is headquartered in Madrid, Spain.

Oryzon Genomics (Oryzon) is a biotechnology company, based in Spain. It develops diagnostic and therapeutic products for the healthcare markets. The company markets its products through its brands name GynEC DX, Cxbladder and ColoBRAF. Oryzon’s product GynEC DX is a new diagnostic test for Endometrial cancer that forms in the lining of the uterus. Its Cxbladder product is a non-invasive bladder cancer diagnostic test for lower abdomen. ColoBRAF is used for the treatment of colorectal cancer, which is common in industrialized countries. The company is certified as per ISO 9001 for quality system management. Oryzon is headquartered in Barcelona, Spain.

Pronota NV (Pronota) is a developer of biomarker discovery, based in Belgium. It focuses on protein biomarkers for identification of candidates for drug development and diagnostic products for diagnosis and personalized treatment of diseases. The company’s products include cardio-rendal, pre-eclampsia, sepsis, and ovarian cancer. Its technologies include MASStermind, a protein biomarker discovery platform that enables the identification and relative quantitation of proteins; and MASSterclass, a mass spectrometry based antibody-free assay platform that provides contract assay development and biomarker screening services. The company also provides contract proteomic research and development services to the pharmaceutical and diagnostic industry. Pronota is headquartered in Zwijnaarde, Belgium.

TherOx, Inc. (TherOx) is a medical device company, based in the US. It develops and commercializes super oxygenation therapy to save heart attack patients. The company’s products include AO system, disposables and downstream system. Its SSO2 therapy consists of a disposable cartridge powered by a transportable system with an easy-to-use interface that delivers a precise concentration of oxygen to the patient’s own blood. The company’s TherOx AO system is a mobile hardware device that interfaces with the TherOx AO cartridge. Its DownStream System is a technology under development for the treatment of heart attack. TherOx is headquartered in Irvine, California, the US.

Volcano Corporation (Volcano) is a medical device company, which develops, manufactures and commercializes therapy products including intravascular ultrasound (IVUS) and fractional flow reserve (FFR) products. Its product offerings include multi-modality consoles, which offer intravascular ultrasound (IVUS), and functional measurement (FM) capabilities. The company operates its business through two business segments, namely, Medical segment and Industrial segment. The Industrial segment is operated through its wholly-owned subsidiary, Axsun Technologies, Inc., which offers micro-optical spectrometers and optical channel monitors. The company markets its products across the US, Europe, South Africa and Japan regions. It has manufacturing facilities in Rancho Cordova, California and Billerica, Massachusetts, the US. Volacano is headquartered in California, the US.

BioResonator is a medical device and biotechnology company, based in Sweden. It develops and markets biomedical sensors and diagnostic systems. The sensors developed by the company are useful for the diagnosis of various diseases. Its products include art manual and art servo. BioResonator focuses on the glaucoma where medical examination is carried out based on intraocular pressure. It has entered into collaborative agreements with various universities and commercial organizations. The company’s research and development activities are focused on the development of resonance technology, scientific verification of the technology and product development in the field of IOP-measurement. Its BioResonator tonometer satisfies ISO 8612:2001 standards. BioResonator is headquartered in Umea, Sweden.

Biopremier is a healthcare and medical device company, based in Portugal. The company research and develops fast and reliable diagnostic methods. It operates through division such as Agri-Food and Clinical. Agri-Food division performs research on food spoilage microorganisms, food certification and meat/fish species identification. Clinical unit develops detection methods for pathogenic microbes. Biopremier develops molecular biology applied to taxonomy, genetic diversity and diagnostics, and laboratory services. The company serves customers such as laboratories, universities, research institutes. It has certification according to 17025:2005 ISO standards. It was incorporated in the year 2003. BIOPREMIER is headquartered in Campo Grande, Portugal.

TcLand Expression (TcLand) is a privately held integrated biotechnology company, based in France. It offers services ranging from research and development, clinical and regulatory, bioinformatics and biostatistics, market access and production. The company focuses on personalized medicine in immunology (auto-immune and transplantation disorders). TcLand also has a pipeline of biomarkers in various development stages. It has entered into several collaboration agreements with the academic clinical centers such as Hospital Clinic Barcelona - Institut de Investigacions Biomediques August Pi i Sunyer (IDIBAPS, Spain), Institut National de la Recherche Médicale (INSERM, France), Reprogramming the Immune System for Establishment of Tolerance and Institute for Transplantation and research in Transplantation (ITERT, France). The company operates through its offices in France and US. TcLand is headquartered in Nantes, France.

Fina Biotech (FN) is a developer of biotechnology project, based in Spain. It operates in the field of autologous adult stem cell therapy, anti-glioblastoma therapy, cancer diagnosis, cancer prognosis, Alzheimer's disease, cardiovascular disease, liver damage marker, and infertility projects. The company also develops kits for the diagnosis, prognosis, and measurement of treatment resistance in various diseases, as well as in cell and antitumor therapy. Its clinical development section produces cell therapy for myocardial infarction, cell therapy for stroke, bladder cancer markers, prostate cancer markers, colon cancer markers, breast cancer markers, and restenosis markers. The company has four of its patents pending out of which three are on patent cooperation treaty phase. FN is headquartered in Madrid, Spain.

Tengion, Inc. (Tengion) is a biopharmaceutical company, which discovers, manufactures and commercializes a variety of neo-organs and neo-tissues, derived from the patients' own cells. The company has its own integrated technology named Organ Regeneration Platform, which harnesses an individual's body ability to regenerate organs and tissues. Currently, the company is conducting clinical trials on Neo-Urinary Conduit for bladder cancer patients and Neo-Kidney Augment for patients suffering from advanced chronic kidney disease. The company is conducting Phase I clinical trial for Neo-Urinary Conduit for translating the surgical implantation procedure,which are utilized in pre-clinical studies, and filed a pre- Investigational New Drug with the US FDA for its Neo-Kidney Augment. Tengion is headquartered in North Carolina, the US.

Global Data Integration Market is expected to grow at a CAGR of 11.07 over the period 2011-2015. One of the key factors contributing to this market growth is increased demand for data governance. The Global Data Integration Market also been witnessing demand for diversified offerings. However, higher product and upgradation costs could pose a challenge to the growth of this market.

Global VoIP Services market in the Telecommunication industry is expected to grow at a CAGR of 7.1 percent over the period 2011-2015. One of the key factors contributing to this market growth is low cost of communication services. The Global VoIP Services market in the Telecommunication industry has also been witnessing the increasing use of session initiation protocol for VoIP services. However, perceived deployment and usability complexity could pose a challenge to the growth of this market.

Global Set Top Box Market is expected to grow at a CAGR of 2.75 percent over the period 2011-2015. One of the key factors contributing to this market growth is the advancement in technology. The Global Set Top Box Market also been witnessing increasing digitization of television networks. However, the high cost for advanced technology set top boxes could pose a challenge to the growth of this market.

Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 report is an essential source of information and analysis on the global Acute Pain Therapeutics market. The report identifies the key trends shaping and driving the global Acute Pain Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products in the global Acute Pain Therapeutics sector.

Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to 2019 report is an essential source of information and analysis on the global Post-Traumatic Stress Disorder (PTSD) Therapeutics market. The report identifies the key trends shaping and driving the global Post-Traumatic Stress Disorder Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products in the global Post-Traumatic Stress Disorder (PTSD) Therapeutics sector.

Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019 report is an essential source of information and analysis on the global neuroendocrine carcinoma market. The report identifies the key trends shaping and driving the market. It also provides insights on the prevalent competitive landscape and the emerging players that are expected to significantly alter the positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products in the global neuroendocrine carcinoma sector.

Varian Medical Systems, Inc. (Varian) is a manufacturer of medical devices and software for the treatment of cancer. Varian designs, manufactures and sells equipment and software for the diagnosis and treatment of cancer and other medical conditions through radiotherapy, radiosurgery, proton therapy and brachytherapy. The company offers X-ray tubes and digital image detectors that are used in medical, dental, veterinary, scientific and industrial sectors. The company designs, manufactures, sells and services linear accelerators, image processing software and image detection products for security and inspection purposes and proton therapy products and systems for cancer treatment. The company, together with its subsidiaries and manufacturing facilities, operates across North America, Europe, Asia-Pacific, the Middle East and Africa. Varian is headquartered in Palo Alto, California, the US.

Artimplant AB (Artimplant) is a biomaterials company providing solutions for the treatment of orthopedic, reconstructive surgery and oral surgery. The company develops, manufactures and markets degradable implants that restores the health of patients and helps the body to heal. The company’s technology is marketed under the brand name Artelon. It serves as a scaffold for tissue ingrowth and provides temporary support for healing tissue. Artelon developed specifically for medical applications and has clinical documentation with long follow-up periods. The company has its operations in the US through subsidiary Artimplant USA. Artimplant is headquartered in Vastra Frolunda, Sweden.

Luminex Corporation (Luminex) is a medical devices company, which develops, manufactures and markets its proprietary biological testing technologies. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. The company operates its business through two reportable business segments, namely, the Technology and Strategic Partnerships (TSP) segment and the Assays and Related Products (ARP) segment. Its TRP segment's product portfolio consists of Luminex LX 100/200, FLEXMAP 3D and MAGPIX; xPONENT, MicroPlex Microspheres, MagPlex Microspheres, xTAG Microspheres, SeroMAP Microspheres, and calibration and control microspheres. The ARP segment comprises assay products including respiratory viral family, gastrointestinal pathogen detection family, MultiCode assays and products family, among others. Luminex offers its product and services in the North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.

Global Telemedicine Market is expected to grow at a CAGR of 18.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the advancements in digital technology used in remote diagnosis of patients. The Global Telemedicine Market also been witnessing increasing adoption of Tele-surgery. However, the high cost of technology could pose a challenge to the growth of this market.

Acute Respiratory Distress Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 report is an essential source of information and analysis on the global Acute Respiratory Distress Syndrome (ARDS) Therapeutics market. The report identifies the key trends shaping and driving the global Acute Respiratory Distress Syndrome (ARDS) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products in the global Acute Respiratory Distress Syndrome (ARDS) Therapeutics sector.